text.skipToContent text.skipToNavigation

Maximum quantity allowed is 999

Please select the quantity

CAS RN: 641571-10-0 | Product Number: N1296

Nilotinib


Purity: >95.0%(T)(HPLC)
Synonyms:
  • 4-Methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[[4-(pyridin-3-yl)pyrimidin-2-yl]amino]benzamide
Product Documents:
1G
125,00 €
Contact Us 14  

*Stock available in Belgium will be delivered in 1 to 3 days
*Stock available in Japan will be delivered in 1 to 2 weeks (excludes regulated items and dry ice shipments).


Product Number N1296
Purity / Analysis Method >95.0%(T)(HPLC)
Molecular Formula / Molecular Weight C__2__8H__2__2F__3N__7O = 529.53 
Physical State (20 deg.C) Solid
Storage Temperature Refrigerated (0-10°C)
Store Under Inert Gas Store under inert gas
Condition to Avoid Air Sensitive,Heat Sensitive
CAS RN 641571-10-0
Reaxys Registry Number 10737140
MDL Number

MFCD09833716

Specifications
Appearance White to Light yellow powder to crystal
Purity(HPLC) min. 95.0 area%
Purity(Volumetric Analysis) min. 95.0 %
Melting point 236.0 to 240.0 °C
NMR confirm to structure
Properties (reference)
Melting Point 238 °C
GHS
Pictogram Pictogram Pictogram
Signal Word Warning
Hazard Statements H361 : Suspected of damaging fertility or the unborn child.
H373 : May cause damage to organs through prolonged or repeated exposure.
H410 : Very toxic to aquatic life with long lasting effects.
Precautionary Statements P273 : Avoid release to the environment.
P260 : Do not breathe dust.
P201 : Obtain special instructions before use.
P280 : Wear protective gloves/ protective clothing/ eye protection/ face protection/ hearing protection.
P391 : Collect spillage.
P308 + P313 : IF exposed or concerned: Get medical advice/ attention.
Related Laws:
RTECS# CV5581770
Transport Information:
UN Number UN3077
Class 9
Packing Group III
HS Number 2933998090
Application
Nilotinib: A BCR-ABL Tyrosine Kinase Inhibitor

Nilotinib (AMN107) is a BCR-ABL tyrosine kinase inhibitor. Nilotinib binds to and stabilizes the inactive conformation of the ATP-binding site of the BCR-ABL protein with higher affinity than imatinib [I0906] [I0936 (mesylate)]. In vitro, nilotinib inhibited BCR-ABL-mediated proliferation of murine leukemia cell lines. (The product is for research use only.)

References


Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.

The requested SDS is not available.

Please Contact Us for more information.

Specifications
C of A & Other Certificates
Please enter Lot Number Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.

The product with the lot number searched for has been discontinued and no related documentation is available.

Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.

A sample C of A for this product is not available at this time.

Analytical Charts
Please enter Lot Number Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.

The requested analytical chart is not available. Sorry for the inconvenience.

The product with the lot number searched for has been discontinued and no related documentation is available.

Other Documents

Session Status
Your session will timeout in 10 minutes. You will be redirected to the HOME page after session timeout. Please click the button to continue session from the same page. minute. You will be redirected to the HOME page after session timeout. Please click the button to continue session from the same page.

Your session has timed out. You will be redirected to the HOME page.